Cargando…
Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
Despite the available chemotherapy and treatment, leukemia remains a difficult disease to cure due to frequent relapses after treatment. Among the heterogeneous leukemic cells, a rare population referred as the leukemic stem cell (LSC), is thought to be responsible for relapses and drug resistance....
Autores principales: | Feng, Qian, Leong, Wa Seng, Liu, Liang, Chan, Wai-In |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273398/ https://www.ncbi.nlm.nih.gov/pubmed/27110755 http://dx.doi.org/10.3390/molecules21040534 |
Ejemplares similares
-
Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers
por: Kaushik, Vivek, et al.
Publicado: (2017) -
The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses
por: Wu, Kan Xing, et al.
Publicado: (2023) -
VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice
por: Gentner, Eva, et al.
Publicado: (2016) -
Cardiac Glycoside Glucoevatromonoside Induces Cancer Type-Specific Cell Death
por: Schneider, Naira F. Z., et al.
Publicado: (2018) -
Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells
por: Suknuntha, Kran, et al.
Publicado: (2015)